Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer

被引:1
作者
Umashankar, Saumya [1 ]
Li, Moming [1 ]
Blevins, Kaylee [1 ]
Kim, Mi-Ok [1 ]
Majure, Melanie [1 ]
Park, John [1 ]
Huppert, Laura A. [1 ]
Melisko, Michelle [1 ]
Rugo, Hope S. [1 ]
Esserman, Laura [1 ]
Chien, A. Jo [1 ]
机构
[1] Univ Calif San Francisco, Helen Diller Family Canc Ctr, San Francisco, CA 94115 USA
关键词
Breast cancer; Young women; Fertility preservation; Endocrine therapy; Family-building in breast cancer; PREMENOPAUSAL WOMEN; OVARIAN-FUNCTION; FERTILITY; CHEMOTHERAPY; TAMOXIFEN; PRESERVATION; PREGNANCY;
D O I
10.1007/s10549-023-07206-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose This study characterizes attitudes and decision-making around the desire for future children in young women newly diagnosed with early-stage breast cancer and assesses how clinical factors and perceived risk may impact these attitudes.Methods This is a prospective study in women < 45 years with newly diagnosed stage 1-3 breast cancer. Patients completed a REDCap survey on fertility and family-building in the setting of hypothetical risk scenarios. Patient, tumor, and treatment characteristics were collected through surveys and medical record.Results Of 140 study patients [median age = 41.4 (range 23-45)], 71 (50.7%) were interested in having children. Women interested in future childbearing were younger than those who were not interested (mean = 35.2 [SD = 5.2] vs 40.9 years [3.90], respectively, p < 0.001), and more likely to be childless (81% vs 31%, p < 0.001). 54 women (77.1% of patients interested in future children) underwent/planned to undergo oocyte/embryo cryopreservation before chemotherapy. Interest in future childbearing decreased with increasing hypothetical recurrence risk, however 17% of patients wanted to have children despite a 75-100% hypothetical recurrence risk. 24.3% of patients wanted to conceive < 2 years from diagnosis, and 35% of patients with hormone receptor positive tumors were not willing to complete 5 years of hormone therapy.Conclusion Many young women diagnosed with early-stage breast cancer prioritize childbearing. Interest in having a biologic child was not associated with standard prognostic risk factors. Interest decreased with increasing hypothetical recurrence risk, though some patients remained committed to future childbearing despite near certain hypothetical risk. Individual risk assessment should be included in family-planning discussions throughout the continuum of care as it can influence decision-making.
引用
收藏
页码:509 / 520
页数:12
相关论文
共 23 条
  • [1] Tamoxifen and pregnancy
    Barthelmes, L
    Gateley, CA
    [J]. BREAST, 2004, 13 (06) : 446 - 451
  • [2] Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer
    Bines, J
    Oleske, DM
    Cobleigh, MA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 1718 - 1729
  • [3] Survival benefit of neoadjuvant chemotherapy for resectable breast cancer: A meta-analysis
    Chen, Yan
    Shi, Xiu-E
    Tian, Jin-Hui
    Yang, Xu-Juan
    Wang, Yong-Feng
    Yang, Ke-Hu
    [J]. MEDICINE, 2018, 97 (20)
  • [4] Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer
    Chien, A. Jo
    Duralde, Erin
    Hwang, Richard
    Tsung, Karen
    Kao, Chia-Ning
    Rugo, Hope S.
    Melisko, Michelle E.
    Esserman, Laura J.
    Munster, Pamela N.
    Cedars, Marcelle
    Kerlikowske, Karla
    McCulloch, Charles E.
    Rosen, Mitch P.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (01) : 173 - 181
  • [5] Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
    Davies, Christina
    Pan, Hongchao
    Godwin, Jon
    Gray, Richard
    Arriagada, Rodrigo
    Raina, Vinod
    Abraham, Mirta
    Medeiros Alencar, Victor Hugo
    Badran, Atef
    Bonfill, Xavier
    Bradbury, Joan
    Clarke, Michael
    Collins, Rory
    Davis, Susan R.
    Delmestri, Antonella
    Forbes, John F.
    Haddad, Peiman
    Hou, Ming-Feng
    Inbar, Moshe
    Khaled, Hussein
    Kielanowska, Joanna
    Kwan, Wing-Hong
    Mathew, Beela S.
    Mittra, Indraneel
    Mueller, Bettina
    Nicolucci, Antonio
    Peralta, Octavio
    Pernas, Fany
    Petruzelka, Lubos
    Pienkowski, Tadeusz
    Radhika, Ramachandran
    Rajan, Balakrishnan
    Rubach, Maryna T.
    Tort, Sera
    Urrutia, Gerard
    Valentini, Miriam
    Wang, Yaochen
    Peto, Richard
    [J]. LANCET, 2013, 381 (9869) : 805 - 816
  • [6] Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancer
    Kim, Jayeon
    Oktay, Kutluk
    Gracia, Clarisa
    Lee, Sanghoon
    Morse, Christopher
    Mersereau, Jennifer E.
    [J]. FERTILITY AND STERILITY, 2012, 97 (03) : 671 - 676
  • [7] Factors associated with treatment delay in women with primary breast cancer who were referred to reproductive specialists
    Kitano, Atsuko
    Shimizu, Chikako
    Yamauchi, Hideko
    Akitani, Fumi
    Shiota, Kyoko
    Miyoshi, Yoko
    Ohde, Sachiko
    [J]. ESMO OPEN, 2019, 4 (02)
  • [8] Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer
    Koga, Chinami
    Akiyoshi, Sayuri
    Ishida, Mayumi
    Nakamura, Yoshiaki
    Ohno, Shinji
    Tokunaga, Eriko
    [J]. BREAST CANCER, 2017, 24 (05) : 714 - 719
  • [9] Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation
    Letourneau, Joseph M.
    Wald, Kaitlyn
    Sinha, Nikita
    Juarez-Hernandez, Flor
    Harris, Eve
    Cedars, Marcelle, I
    McCulloch, Charles E.
    Dolezal, Milana
    Chien, A. Jo
    Rosen, Mitchell P.
    [J]. CANCER, 2020, 126 (03) : 487 - 495
  • [10] Little RJA., 2002, Statistical Analysis with Missing Data, V2nd ed., DOI [10.1002/9781119013563, DOI 10.1002/9781119013563]